Effects of FPL-55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart

Lillie M. Boyd, David Ezra, Giora Feuerstein, Robert E. Goldstein*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Intracoronary leukotriene D4, 0.1-3.0 μg (0.2-6.0 nmol), produced dose-dependent decreases in coronary flow of anesthetized pigs. Pretreatment with intracoronary FPL-55712 (0.1, 0.3 and 1.0 mg) reduced coronary constriction due to 1.0 μg leukotriene D4 by up to 77%. FPL-55712 did not produce sustained alterations is coronary flow, left ventricular end-diastolic pressure, systemic arterial pressure, or heart rate. Indomethacin pretreatment (6 mg/kg i.v.) had no effect on leukotriene-induced coronary constriction. Inhibition produced by FPL-55712 may be useful in disease states involving leukotriene-mediated coronary constriction.

Original languageEnglish
Pages (from-to)307-311
Number of pages5
JournalEuropean Journal of Pharmacology
Volume89
Issue number3-4
DOIs
StatePublished - 6 May 1983
Externally publishedYes

Keywords

  • Coronary constriction
  • FPL-55712
  • Indomethacin
  • Leukotriene D

Fingerprint

Dive into the research topics of 'Effects of FPL-55712 or indomethacin on leukotriene-induced coronary constriction in the intact pig heart'. Together they form a unique fingerprint.

Cite this